← SynDRA
PHENSUXIMIDE
SynDRA canonical compound SYN0001909 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | succinimide antiepileptic |
|---|
| Indication | seizures |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- CACNA1H BLOCKER
- Voltage-gated T-type calcium channel blocker
- CACNA1G BLOCKER
- CACNA1I BLOCKER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- HTR1A
- HTR2B
- HTR2C
- HTR3A
- IDH1
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SAMHD1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HTR2A
- HRH3
- ADORA2A
- HRH2
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
Drug classes
- succinimide antiepileptic
ATC classes
Cross-references
Synonyms
- MILONTIN
- phensuccimide
- phensuximid
- RS-Phensuximide
- racemic phensuximide
- succitimal
- fensuccimide
- Fensuximida
- 1-methyl-3-phenylsuccinimide
- Epimid
- Lifene
- Milonton
- Mirontin
- N-methyl-3-phenylpyrrolidinedione
- Phensuximid
- Racemic phensuximide
- Succitimal
- NSC-760079
- PM-334
- Milontin
- Phenylsuximide
- Fensuccimide
- Fenosuccimide
- Phensuximidum
- Methylphenylsuccinimide
- Fensuccimide [DCIT]
- Succinimide, N-methyl-2-phenyl-
- Phensuximidum [INN-Latin]
- Fensuximida [INN-Spanish]
- N-Methyl-alpha-phenylsuccinimide
- PM 334
- N-Methyl-2-phenylsuccinimide
- Milontin (TN)
- EINECS 201-664-6
- 1-Methyl-3-Phenylsuccinimide
- NSC 760079
- 6WVL9C355G
- N-METHYL-3-PHENYLPYRROLIDINEDIONE
Look up PHENSUXIMIDE in the interactive SynDRA portal →